The invention relates to aqueous formulations containing
(-)-(R)-3-(2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluobutane-1-su-
lfonate. Said formulations are suitable as infusion solutions or as
concentrate for producing these infusion solutions.